Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples.
Am J Drug Alcohol Abuse
; 35(5): 375-80, 2009.
Article
in En
| MEDLINE
| ID: mdl-20180667
ABSTRACT
BACKGROUND:
Little is known about the prevalence and severity of smoking in pregnant opioid dependent patients.OBJECTIVES:
To first characterize the prevalence and severity of smoking in pregnant patients screened for a randomized controlled trial, Maternal Opioid Treatment Human Experimental Research (MOTHER), comparing two agonist medications; and second, to compare the MOTHER screening sample to published samples of other pregnant and/or patients with substances use disorders.METHODS:
Pregnant women (N = 108) screened for entry into an agonist medication comparison study were retrospectively compared on smoking variables to samples of pregnant methadone-maintained patients (N = 50), pregnant opioid or cocaine dependent patients (N = 240), non-pregnant methadone-maintained women (N = 75), and pregnant non-drug-addicted patients (N = 1,516).RESULTS:
Of screened patients, 88% (n = 95) smoked for a mean of 140 months (SD = 79.0) starting at a mean age of 14 (SD = 3.5). This rate was similar to substance use disordered patients and significantly higher compared to general pregnant patients (88% vs. 22%, p < .001). CONCLUSION AND SCIENTIFICSIGNIFICANCE:
Aggressive efforts are needed to reduce/eliminate smoking in substance-abusing pregnant women.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Smoking
/
Cocaine-Related Disorders
/
Methadone
/
Opioid-Related Disorders
Type of study:
Clinical_trials
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Pregnancy
Language:
En
Journal:
Am J Drug Alcohol Abuse
Year:
2009
Document type:
Article
Affiliation country:
Estados Unidos